Total judgment to exceed $183 million
CHICAGO, Aug. 4, 2022 /PRNewswire/ -- A jury has ordered Eli Lilly and Company to pay over $61 million in damages eight years after whistleblower Ronald J. Streck filed a False Claims Act lawsuit alleging that the pharmaceutical company underpaid the rebates required of drug manufacturers under the Medicaid Drug Rebate Program. Under the False Claims Act, damages are trebled and the final judgment will be over $183 million.
Dan Miller of Walden Macht & Haran, lead counsel to Streck, said, "The jury has spoken. Eli Lilly knowingly violated the False Claims Act and defrauded the Medicaid Program of $61 million in taxpayer money. We took on one of the biggest pharmaceutical companies in the world, and one of the largest law firms in the world, and we won. We are very proud to represent Mr. Streck in this quest, which began more than eight years ago."
The $61 million award is the latest in Streck's series of successful False Claims Act lawsuits against drug manufacturers for alleged misconduct involving the Medicaid Drug Rebate Program, including a $75 million settlement with Bristol Myers Squibb and an $18 million settlement with Astellas Pharma U.S. last year. Collectively, Streck's lawsuits have recovered more than $350 million for the Medicaid program. Miller has represented Mr. Streck across all of his whistleblowing cases.
The Department of Justice announced the settlement agreements regarding Streck's previous claims with ...
A waste disposal company won dismissal of a False Claims Act suit alleging it improperly billed the federal and Montana governments for services it didn’t provide. Whistleblowers Max Bauer Jr. and...